High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from CHARISMA trial

: Weber M, Bhatt DL, Brennan DM, Hankey GJ, Steinhubl SR, Johnston SC, Montalescot G, Mak K-H, Fox KAA, Easton DJ, Topol EJ, Hamm CW, Airaksinen J

: 2011

: Heart

: 97

: 8

: 626

: 631

: 6

: 1355-6037

DOI: https://doi.org/10.1136/hrt.2010.210419(external)